How a leading biotechnology company partnered with InfinixBio to engineer and deliver usable strains for their line of custom therapeutic antibodies

Bioproduction Services for Innovative Solutions

Just over 10 years ago, a company focused on product development in the genetic engineering space approached our team with a problem: their efforts to develop a complete platform strain required scientific resources that would have otherwise been devoted to protein development.

In addition to being time-consuming and unpredictable, the process was hindering their previously established production goals. The company wanted InfinixBio’s expert assistance engineering production cell lines for therapeutic protein development.

Bioproduction ServicesLeveraging extensive genetic engineering and cell biology expertise, as well as advanced knowledge of Lambda Red recombineering-based chromosomal engineering, CRISPR-mediated genome editing, and synthetic DNA design versatility, we began working toward optimizing our client’s production cell lines.

Throughout the early stages of the strain development and optimization process, there were numerous challenges related to cell growth and stability, protein production levels, and unexpected engineering results.

Our team quickly and efficiently worked through these issues to develop value-driven therapeutic protein development production cell lines.

We have continued our professional relationship with this client for over a decade.

  • Engineered and delivered usable strains on-time and within budget
  • Reduced development risks associated with genetic engineering
  • Enabled our client to allocate their time/resources to other projects
  • Improved overall efficiency and efficacy of the production process
  • Supported 11 years of successful, value-driven collaboration

Looking for a trusted partner for your pre-clinical toxicology studies?

Our experienced lab team is here to help. Reach out today to learn more.